Stockwinners Market Radar for March 23, 2022 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

20:14 EDT Domo COO sells $515K in common stock - In a regulatory filing, Domo disclosed that its COO Catherine Wong sold 10.5K shares of common stock on March 17, 2022 in a total transaction size of $515.4K.

20:11 EDT Adaptive Biotechnologies buys 45K shares of Adaptive Biotechnologies today

20:06 EDT Moderna finalizes strategic partnership with Australian government - Moderna "announced the finalization of a strategic partnership with the Australian Federal Government to establish a state-of-the-art, domestic mRNA vaccine manufacturing facility in Australia. This finalizes the agreement in principle with the Australian Federal Government announced in December 2021. The facility, when constructed, is expected to provide people in Australia with access to a domestically manufactured portfolio of mRNA vaccines against respiratory viruses, including COVID-19, seasonal influenza, respiratory syncytial virus, and other potential respiratory viruses, pending licensure."

17:41 EDT BankUnited raises quarterly dividend 9% to 25c from 23c per share - The dividend will be payable on April 29 to stockholders of record at the close of business on April 14.

17:32 EDT Granite awarded $75M roadway Ppoject in Las Vegas - Granite has been awarded the approximately $75M contract for the I-515 and Charleston Boulevard Interchange improvement project by the Nevada Department of Transportation. Located in Las Vegas, this project is being completed via the Construction Manager at Risk project delivery method. Granite was originally hired in 2017 to provide preconstruction services. The project is expected to start in August 2022 and projected to be completed in Q2 2024.

17:23 EDT KB Home sees Q2 housing revenue $1.55B-$1.65B - Sees Q2 average selling price $490,000. Sees Q2 homebuilding operating interest margin 14.3%-14.7%. Sees Q2 gross profit margin 24.4%-25%. Sees Q2 SG&A expense ratio 10%-10.5%. Sees Q2 effective tax rate 25%. Sees Q2 community count . Says cancellation rate remains well below historical levels. Says housing revenues up in all four region. Says well positioned for Spring selling season. Sees sequential increases for community count in each remaining quarter. Comments taken from Q1 earnings conference call.

17:19 EDT Quest Diagnostics grated CDC $19.5M contract for COVID vaccination research - Quest Diagnostics "announced that it has been granted a contract by the Centers for Disease Control and Prevention to perform testing and provide laboratory data analysis to help identify patterns in SARS-COV-2 seroprevalence on a multistate basis. The goal is to aid the CDC in assessing the proportion of the population that has been infected by or vaccinated against SARS-CoV-2, the virus that causes COVID-19. Quest was awarded the contract following a competitive bid. The total contract value with all options is valued at up to approximately $19.5M."

17:00 EDT Ollie's Bargain Outlet CFO says comps QTD trading 'little ahead of guidance' - CEO John Swygert also states: "With regards to 2022 in the back half, we just believe that, first and foremost, lapping the stimulus and getting all the stimulus out of the way is paramount to us getting back to running our normal business. But most importantly, we believe the second half will be able to lap what we had talked about a lot in Q3 of last year with regards to the delayed shipments, I'll call it, the challenges we had with the late arriving import product and the holiday product that basically collide with all of our closeout goods that were domestically sourced and we had to prioritize the way we moved our product through last year and the disruption we created. With that, we just believe we're set up and we're positioned in a much, much better shape this year with our supply chain. Our distribution centers are running at the right throughput levels that we'll be in much better position to really kick off once we clear the stimulus here that started in March of last year. And we think ran through a good part of May, almost the end of May. So I think once we see that get out of the way and the position of inventory and store in a much better condition will be ready to go. And obviously, I think 1 of the big takeaways you mentioned I forgot about is the deal flow is really starting to pick up, and we're starting to see some things shake loose. And I think we're in a position here on (inaudible) we're going to see some big benefits." Comments taken from Q4 earnings conference call.

16:44 EDT Riot Blockchain COO to leave April 7th - In a regulatory filing, Riot Blockchain announced that it has entered into a separation agreement with COO Megan M. Brooks-Anderson effective April 7, 2022, stating: "Immediately and without further action as of the Separation Date, Executive shall cease to be the Company's Chief Operating Officer and be deemed to have resigned from all positions, titles, duties, authorities, and responsibilities at or with the Company, and Executive's employment with the Company shall end. To help facilitate a smooth transition following the cessation of Executive's employment with the Company, Executive shall, for the period commencing on the Separation Date and ending as of July 7, 2022, unless earlier terminated as provided herein, assist the Company on an as needed basis in a non-employee consultant capacity with respect to certain transition matters and perform such related duties as may reasonably be requested of Executive by the Company."

16:39 EDT Novartis announces FDA approval of Pluvicto - Novartis announced that the U.S. Food and Drug Administration approved Pluvicto, formerly referred to as (177) Lu-PSMA-617, for the treatment of adult patients with a certain type of advanced cancer called prostate-specific membrane antigen--positive metastatic castration-resistant prostate cancer, or PSMA-positive mCRPC, that has spread to other parts of the body. These patients have already been treated with other anticancer treatments, the company noted. Pluvicto is the first FDA-approved targeted radioligand therapy for eligible patients with mCRPC that combines a targeting compound, or ligand, with a therapeutic radioisotope, or a radioactive particle, the company said. Pluvicto is expected to be available to physicians and patients within weeks, Novartis noted. Pluvicto and Locametz are registered products of Advanced Accelerator Applications, the radioligand business of Novartis, approved in the United States for physicians to prescribe to appropriate patients, the company noted.

16:29 EDT Imago BioSciences appoints Michael Arenberg to chief operating, business officer - Imago BioSciences announced the appointment of Michael Arenberg to chief operating and business officer. Arenberg is a biopharmaceutical executive who will be charged with leading strategic operations, investor relations, commercial development and business development of Imago.

16:25 EDT 3D Systems partners with Enhatch to scale personalized medical device delivery - 3D Systems and Enhatch, the Hoboken, New Jersey and Tulsa, Oklahoma-based developer of the Intelligent Surgery Ecosystem, have entered a partnership. The technologies which drive Intelligent Surgery aim to streamline and scale the design and delivery of patient-specific medical devices by automating the process. Incorporating these capabilities into 3D Systems' workflow for patient-specific solutions will help meet the growing demand for personalized medical devices. 3D Systems partners with medical device manufacturers to offer its VSP surgical planning solutions to support craniomaxillofacial and orthopedic medical specialties to help reduce procedure time and improve surgical outcomes. Likewise, Enhatch develops software applications powered by artificial intelligence to streamline every element of the patient-specific digital workflow. Combining both companies creates an optimized, automated, and scalable medical device workflow.

16:21 EDT Ligand to spin-off its OmniAb business through Avista Public Acquisition merger - Ligand Pharmaceuticals (LGND) "announced the signing of a definitive merger agreement with Avista Public Acquisition Corp. II (AHPA), a publicly traded special purpose acquisition company providing for the spin-off of OmniAb, Ligand's antibody discovery business, immediately followed by a merger with a newly formed subsidiary of APAC. The combined company will be led by Ligand's President, Matt Foehr, and will be renamed "OmniAb, Inc." Upon the closing of the transaction, Avista Capital Partners, APAC's sponsor and a leading private equity firm focused on the healthcare industry, has agreed to invest up to $115M in the combined company, and Ligand will contribute $15M. The combined company will have an initial pre-money equity valuation of $850M. Immediately prior to the transaction close, Ligand intends to distribute 100% of its ownership of OmniAb to Ligand shareholders in a tax-free distribution. The transaction is expected to close in the second half of 2022."

16:15 EDT Playtika acquires JustPlay.LOL, terms not stated - Playtika Holding "announced the acquisition of Israel-based, JustPlay.LOL, creator of the multiplayer game, 1v1.LOL, which expands the company's offering into the Action and Battle Royale genres. The acquisition is consistent with Playtika's strategy to increase its breadth of entertainment genres and leverage the company's Boost platform to enhance game-operations."

16:08 EDT PS Business Parks CEO Chandler steps down for health reasons - PS Business Parks, Inc. announced that Dan "Mac" Chandler, III, the company's President and Chief Executive Officer, who has been on medical leave since January 17, 2022, will step down as President and Chief Executive Officer and as a member of the Board of Directors for health reasons, effective March 23, 2022. Stephen W. Wilson, who was appointed interim President and Chief Executive Officer on January 17, 2022, will continue to serve in that role, and will continue to be supported by the company's senior management team, including Maria R. Hawthorne, interim Chief Operating Officer, and Adeel Khan, Chief Financial Officer. Chandler said, "While it has been an honor to lead this inspiring company, I must step down as President and CEO due to my health condition. I am confident that Steve, Maria, Adeel, and the rest of the management team will continue to lead the Company effectively and in the interest of our stockholders." Ronald L. Havner, Jr., the company's Chairman of the Board, said, "On behalf of the Board and all the Company's employees, we thank Mac for his efforts as our CEO and offer him and his family our best wishes."

16:05 EDT Spotify and Google announce 'User Choice Billing' - In a blog post, Spotify stated: "Today, we are excited to announce a new chapter in our partnership with Google: a multiyear agreement that represents a first-of-its-kind option in payment choice and offers opportunities for both consumers and developers. Users who've downloaded Spotify from the Google Play Store will be presented with a choice to pay with either Spotify's payment system or with Google Play Billing. For the first time, these two options will live side by side in the app. This will give everyone the freedom to subscribe and make purchases using the payment option of their choice directly in the Spotify app. Spotify will continue to freely communicate with users about our Premium subscription service, promote discounts and promotions, and give listeners on our Free tier the ability to convert to Premium directly in the app. Over the coming months, Spotify will work with Google's product and engineering teams to build this new experience, and we'll roll out in countries around the world. Working together, the companies will test and learn, jointly exploring product innovations across the Android platform. We anticipate launching the first iteration of User Choice Billing later this year." Reference Link

16:04 EDT CSX recommends shareholders reject 'mini-tender' offer by TRC - CSX announced that it received notice of an unsolicited "mini-tender" offer by TRC Capital Investment, or TRC, to purchase up to 4M shares of CSX common stock at a price of $34.75 per share in cash. The offer price is 4.43% below the $36.34 closing price of CSX common stock on March 18, the last trading day before the mini-tender commenced. CSX is not affiliated with TRC and does not endorse TRC's unsolicited offer. CSX recommends that CSX shareholders do not tender their shares in response to the offer because the offer is at a price below the current market price for CSX shares. The offer is also subject to a number of conditions, including TRC's ability to secure sufficient financing to consummate the offer. CSX also recommends that any shareholders who have tendered shares to TRC withdraw those shares by providing the written notice described in the offering documentation before the expiration of the offer.

15:51 EDT Instacart announces launch of Instacart Platform - Instacart confirmed the launch of the new "Instacart Platform," via which it said it is "further enabling grocers' digital transformation with a new suite of enterprise-grade technologies to power the future of grocery." The company stated: "With Instacart Platform, the company is giving retailers access to the technologies behind Instacart's consumer marketplace to power their own digital properties and retail operations. Instacart Platform brings together the technologies retailers need to improve the consumer experience online or in-store and digitize the end-to-end grocery operation. Some retailers will choose to use some of these technologies a-la-carte, while others might benefit from having all of these solutions on one connected platform that works seamlessly across channels." Publicly traded companies in the food delivery space include Just Eat Takeaway.com (JTKWY), DoorDash (DASH) and Uber (UBER).

15:42 EDT Studio City International Holdings Limited (Class A ADS) trading halted, volatility trading pause

14:51 EDT Chesapeake affiliate opens CNG fueling station in Port Wentworth, Georgia - Chesapeake Utilities Corporation announced that its affiliate Marlin Compression opened a high-capacity compressed natural gas truck and tube trailer fueling station in Port Wentworth, Georgia. The facility is one of the largest public access CNG stations on the East Coast. In addition to CNG, the new fueling station will offer a renewable natural gas option to customers in the near future. In addition to fleet fueling, the station will be utilized as a staging area for Marlin Gas Services to fill CNG transport trailers for its virtual pipeline services. "The Marlin Compression CNG station is yet another example of Chesapeake Utilities' leadership in the transition to lower carbon energy," said Jeff Householder, president and CEO. "Our service expansions not only provide access to lower carbon energy, but they also contribute to the economic well-being of the communities we serve. In partnership with Atlanta Gas Light, Southern Company Gas and the Port Fuel Center, we are excited to offer CNG as a low emissions fuel option for the truck fleets and other vehicles that operate in and around the Port of Savannah. In the near future, we will provide an RNG option at the same site to further advance our efforts in developing sustainable energy projects."

14:03 EDT Redfin announces nationwide launch of rental search offering - Redfin announced it has launched nationwide rental search, which it said lets consumers "search for both rental and for-sale home listings on Redfin for the first time." Redfin said: "Built on the same map-based search technology used by tens of millions to find homes for sale, the addition of rentals makes Redfin a destination for everyone in the U.S. looking for a place to live. Redfin's rental search is powered by rental listings from RentPath, a leading marketing technology and services platform for the rental industry that operates Rent.com and other popular rental sites, which Redfin acquired in April 2021. This significantly expands the reach of the RentPath network, letting RentPath's property-management customers market their rental listings to Redfin.com's 47 million monthly visitors." Redfin CEO Glenn Kelman added: "Adding rental listings to Redfin.com will increase our authority as a real estate destination, not only drawing more visitors to rental listings, but also to our existing for-sale listings. With about one in five Redfin.com visitors interested in rentals, we have an opportunity to generate as many rental inquiries from Redfin.com as from all other RentPath sites. As a result, we expect to attract more property managers to promote their listings on Redfin.com, and for Redfin.com traffic growth to accelerate."

13:31 EDT T-Mobile announces 5G partnership with Disney StudioLAB - T-Mobile (TMUS) announced a five-year innovation partnership with Disney (DIS) Studios StudioLAB. T-Mobile and StudioLAB plan to explore emerging technologies such as virtual presence, Mixed Reality and immersive experiences for consumers. In addition, the teams plan to use Ultra Capacity 5G to test new, more efficient ways to capture, produce and distribute content, both from inside a studio as well as from remote locations. "As America's 5G powerhouse, T-Mobile will collaborate with StudioLAB on new ways to improve content production and test new forms of immersive experiences for consumers using its largest and fastest nationwide 5G network," the company stated.

12:49 EDT Weibo added to SEC provisional list of companies under HFCAA - Weibo was added to the Securities and Exchange Commission's provisional list of companies identified under the Holding Foreign Companies Accountable Act. The statute requires the SEC to identify public companies "that have retained a registered public accounting firm to issue an audit report where the firm has a branch or office that: (1) is located in a foreign jurisdiction, and (2) the Public Company Accounting Oversight Board has determined that it is unable to inspect or investigate completely because of a position taken by an authority in the foreign jurisdiction." Shares of Weibo are down 4% to $25.92 following the news. Reference Link

12:02 EDT Winnebago falls -8.6% - Winnebago is down -8.6%, or -$5.37 to $57.01.

12:01 EDT Worthington falls -13.2% - Worthington is down -13.2%, or -$8.21 to $53.93.

12:00 EDT GameStop rises 15.8% - GameStop is up 15.8%, or $19.49 to $142.63.

11:51 EDT NFL, StatusPRO to develop NFL-licensed VR game for Meta Quest, PSVR - The National Football League and StatusPRO, a sports technology and gaming company that uses real-time player data to create authentic extended reality experiences, announced a partnership to bring an NFL-licensed virtual reality simulation gaming title to fans globally. Available on Meta Quest (FB) and PlayStation VR (SONY), this title will bring fans closer to the gridiron than ever before, allowing them to play like a professional football player through a first-person 3D immersive experience, the NFL said. "Virtual reality gaming is rapidly expanding and our partnership with StatusPRO allows us to explore a new immersive version of NFL gaming with support of the two largest VR platforms within this emerging space," said Joe Ruggiero, SVP, Consumer Products at the NFL. "We are seeing a growing number of fans engaging with VR and we're excited to launch the first-ever VR gaming title that complements our existing offerings in the market today." Release dates and additional information about the NFL's and StatusPRO's new gaming title will be announced at a later date. Reference Link

11:46 EDT Warner Bros. 'Suicide Squad' game delayed to Spring 2023 - Sefton Hill, creative director at video game studio Rocksteady, confirmed that the company's upcoming DC comics game "Suicide Squad: Kill The Justice League" will be delayed to Spring 2023. "I know a delay is frustrating but that time is going into making the best game we can," Hill said. "I look forward to bringing the chaos to Metropolis together. Thanks for your patience." The Fly notes that the game is being published by Warner Bros. (T) and will be releasing for PC, Xbox Series X/S (MSFT), and PlayStation 5 (SONY). Reference Link

11:40 EDT Neurosense Therapeutics Ltd trading halted, volatility trading pause

11:32 EDT Nexstar says Nexstar Digital unique users grew 45% year-over-year in January - Nexstar Digital, the digital division of Nexstar Media, a wholly owned subsidiary of Nexstar Media Group, announced that total unique users to its websites and mobile applications in January 2022 increased by more than 45% from the same time period a year earlier, to 133 million, generating 820 million page views according to Comscore Media Trend. "This growth moved Nexstar Digital into the Comscore Top 25 for unique visitors and marked the seventh consecutive month of growth of at least two million unique users across Nexstar Digital's websites and mobile applications. Collectively, Nexstar Digital's websites and apps now reach close to 50% of the U.S. internet audience," the company stated.

11:06 EDT Meta's Instagram announces new ways to control feed, Favorites and Following - Adam Mosseri, Head of Instagram, said in a blog post: "Today, we're introducing Favorites and Following, two new ways to choose what you see in your feed. We want you to be able to shape Instagram into the best possible experience, and giving you ways to quickly see what you're most interested in is an important step in that direction... Over time, we're going to add more recommendations to your feed based on your interests - Favorites and Following are new ways to catch up on recent posts from the accounts you follow. Favorites shows you the latest from accounts that you choose, like your best friends and favorite creators. In addition to this view, posts from accounts in Favorites will also show up higher in your home feed. Following shows you posts from the people you follow. Both Favorites and Following will show you posts in chronological order, so you can quickly catch up on recent posts." Reference Link

10:53 EDT Marsh McLennan increases share repurchase program by $5B to $6.3B - The board of directors of Marsh McLennan authorized an additional $5B in share repurchases. This is in addition to the company's existing share repurchase program, which had approximately $1.3B of remaining authorization as of December 31, 2021. The total authorization increased to approximately $6.3B, before any share repurchase in the first quarter. The board also declared a quarterly dividend of 53.5c per share on outstanding common stock, payable on May 13 to stockholders of record on April 6, the company announced.

10:15 EDT Spartan Acquisition III Corp trading halted, volatility trading pause

10:01 EDT Sirius XM signs multi-platform agreement with Crooked Media - SiriusXM announced a multi-platform agreement with Crooked Media, the independent progressive media company credited with some of the most popular and critically acclaimed podcasts in the U.S. and abroad. As part of the agreement, Crooked Media's top-ranked podcasts, including Pod Save America, Lovett or Leave It, and Pod Save the World, will join the SiriusXM network through the 2024 election cycle and beyond. The agreement gives SXM Media, the advertising sales arm of Sirius XM Holdings Inc., exclusive global ad sales rights to Crooked Media's extensive lineup of podcasts starting in May. SXM Media also gains sales and sponsorship rights to digital video, social media, and live events produced by Crooked Media. Since 2017, Crooked Media has launched over 25 podcasts and podcast series, including Pod Save America, Keep It, and Wind of Change, and has amassed over 25 awards. Today, Crooked Media's slate of podcasts generate over 21 million monthly downloads. Per Edison Research, SXM Media is the #1 U.S. podcast advertising network in weekly listener reach. SiriusXM is expected to use its multi-platform scale to reach an even larger audience for the voices of Crooked Media's podcasts, including listeners of SiriusXM radio channels, whose paid subscribers total more than 32 million. Crooked Media will retain editorial control of its podcasts and, as a result of this new agreement, is anticipated to expand its network of podcasts over the next three years, as well as further invest in the development, distribution and marketing of its existing podcasts. SiriusXM will also distribute both audio and video content from Crooked Media's podcasts on SiriusXM, including on its radio platform and the SXM App. The Crooked Media podcasts join a growing, diverse lineup of political and entertainment programming available across SiriusXM.

10:00 EDT KE Holdings falls -8.0% - KE Holdings is down -8.0%, or -$1.04 to $11.99.

10:00 EDT Peabody Energy rises 8.9% - Peabody Energy is up 8.9%, or $2.10 to $25.69.

10:00 EDT GameStop rises 13.0% - GameStop is up 13.0%, or $15.96 to $139.10.

09:47 EDT ATRenew falls -4.6% - ATRenew is down -4.6%, or -17c to $3.52.

09:47 EDT Winnebago falls -8.6% - Winnebago is down -8.6%, or -$5.38 to $57.00.

09:47 EDT Clear Secure rises 9.6% - Clear Secure is up 9.6%, or $2.09 to $23.84.

09:22 EDT JetBlue, American announce 'perks' for TrueBlue Mosaic and AAdvantage members - JetBlue (JBLU) and American Airlines (AAL) are elevating the travel experience for its most loyal travelers, announcing new perks for TrueBlue Mosaic and AAdvantage status members when traveling on either. It is the latest round of customer benefits made possible by the airlines' innovative Northeast Alliance, NEA. "We know our most loyal customers love the added perks and flexibility that come with being a TrueBlue Mosaic member, which is why, together with American, we're extending more great benefits to our travelers when they are flying on American-operated flights," said Don Uselmann, vice president loyalty & personalization, JetBlue. "At the same time, we continue to add value to our Northeast Alliance by also extending additional perks and flexibility to American's status members when they fly JetBlue. It's another win as we continue to add value to our loyalty programs." "American and JetBlue are committed to delivering a seamless travel experience to customers through our Northeast Alliance," said Alison Taylor, American's Chief Customer Officer. "Part of that dedication includes making travel even more enjoyable for our loyal members, who inspired this opportunity. "

09:16 EDT Nutra Pharma Corp announces first manufacturing agreement - Nutra Pharma Corporation is announcing their first agreement to act as a product formulator and contract manufacturer for an outside company, Avini Health. "We've spent the last two years bringing all of our manufacturing in-house," stated Rik Deitsch, CEO of Nutra Pharma. "These manufacturing capabilities allow us to produce all of our own products; but also provides the option to act as a contract manufacturer for other companies to potentially provide an additional revenue stream for Nutra Pharma," he continued. "To that end, we have just signed our first contract with an outside company to provide them with formulation expertise, product ideation and manufacturing of finished goods. Making these additional products also allows us to potentially lower our own manufacturing costs as we take advantage of economies of scale to purchase packaging and raw materials. This relationship has already provided revenues and we expect this revenue stream to become substantial over the next few quarters," he concluded.

09:09 EDT XFuels confirms relocation to the state of Texas - Xfuels announced that it has relocated from Alberta, Canada to Texas. The move is intended to help the company expand within the United States. Xfuels also clarified that any new LOI for the purchase of Jubilee Exploration in the United States will be entered under new terms.

09:07 EDT Wix.com announces Amazon multi-channel fulfillment app - Wix.com (WIX) announced a new integration with Amazon (AMZN) Multi-Channel Fulfillment that allows Wix eCommerce merchants to easily fulfill their eCommerce orders using Amazon's order fulfillment services with one- and two-day shipping needs. Wix eCommerce merchants in the US, whether they sell on Amazon or not, can download the Amazon MCF app to their Wix store and more easily access Amazon's fulfillment network, operational expertise, lower fulfillment costs and order delivery in as fast as 1 day. Once merchants integrate, their customers will automatically see shipping speed options and real-time delivery dates from Amazon. This integration reduces the complexities business owners face fulfilling orders on their own and opens the door for them to easily scale and focus on their growth.

09:06 EDT Transcode Therapeutics publishes article in journal Cancers - TransCode Therapeutics, in collaboration with teams from, Massachusetts General Hospital, Michigan State University and Northeastern University, published an article in the journal Cancers titled, Clinical Applications of Short Non-Coding RNA-Based Therapies in the Era of Precision Medicine. The article was published on March 21, 2022. The article describes the development, challenges, and clinical successes of short RNA-based drugs and details several examples of how these RNA drugs are designed, chemically modified, and delivered for treatment of cancer, cardiovascular disease, and rare genetic disorders. In addition, the article highlights key similarities and differences between various short non-coding RNA platforms and discusses considerations to maximize treatment efficacy of RNA-based therapeutics. TransCode's CEO, Michael Dudley, added, "We believe RNA-based drugs will play an increasingly important role in personalized treatment for cancer and other diseases. Our first-in-human clinical trial which we intend to initiate later this year with our lead therapeutic candidate, targets an RNA molecule that has been shown to be the driver of metastatic disease. Since our proprietary delivery system has been engineered to deliver RNA therapeutics inside tumor cells, it has the potential to overcome the challenges of RNA delivery to a range of genetic targets. We believe this would represent a major step forward in unlocking therapeutic access to genetic targets involved in a range of cancers."

09:05 EDT General Mills 'mostly' hedged on commodities through rest of CY

09:05 EDT Muscle Maker's Pokemoto division enters New Jersey - Muscle Maker announced the signing of a new Pokemoto franchise agreement for the Hoboken, New Jersey area. This new franchise agreement marks the first entry for Pokemoto into the New Jersey market. Michael Roper, CEO of Pokemoto, commented, "while it's exciting to sign new franchise agreements and expand into new states, it's even more exciting to get them opened. We currently have 6 franchise locations and 2 additional Company owned locations under construction and multiple LOIs for leases being negotiated. Once opened, Pokemoto will have locations operating across Connecticut, Massachusetts, New York, Rhode Island, Virginia, Maryland, Mississippi, Florida and now New Jersey."

09:04 EDT Beyond Meat, PepsiCo announce debut of Beyond Meat Jerky - Beyond Meat (BYND) and PepsiCo (PEP) announced the debut of Beyond Meat Jerky. The delicious and convenient plant-based jerky is the first product from the two companies' joint-venture, Planet Partnership, LLC. Rolling out at stores nationwide starting in March, Beyond Meat Jerky offers a full-flavored, on-the-go snack experience that furthers Beyond Meat and PepsiCo's shared passion for creating products that are better for both people and the planet. Beyond Meat Jerky is marinated and slow roasted to offer the savory experience of traditional beef jerky in three flavors: Original, Hot & Spicy and Teriyaki. Beyond Meat Jerky contains 10g of protein per serving, no cholesterol, and is made with simple, plant-based ingredients like peas and mung beans, all without GMOs, soy or gluten. Available in three different sized packs, Beyond Meat Jerky is Beyond Meat's first shelf-stable product, unlocking new channels of distribution with availability everywhere from grocery stores to gas stations, and club stores to pharmacies, powering better-for-you snacking that's both convenient and accessible.

09:02 EDT Luxfer names Andrew Butcher as CEO - Luxfer announced that Andrew Butcher has been named as CEO and a member of Luxfer's board of directors, effective May 6. The company also reaffirmed its prior financial guidance for the year. Alok Maskara, who has served as CEO and executive director since May 2017, has elected to leave the company in pursuit of another opportunity.

09:02 EDT Lennox names Alok Maskara as CEO, effective May 9 - Lennox (LII) has appointed Alok Maskara as CEO, effective on May 9. Maskara succeeds Todd Bluedorn, who announced in July 2021 his plans to step down by mid-2022 as Chairman and CEO after 15 years in the role. Todd Teske, current Lead Independent Director since 2015 and board member since 2011, is appointed Chairman of the Board and will also serve as interim CEO until Alok assumes the role as CEO. The company also reiterates its previously announced financial guidance for 2022. Alok brings 25 years of global leadership experience in manufacturing and technology. He has served for five years as CEO of Luxfer Holdings (LXFR).

09:00 EDT SuperCom awarded Croatia's first national electronic monitoring project - SuperCom was awarded by the Ministry of Justice and Administration of Croatia the first full-scale electronic monitoring contract in the country and will deploy SuperCom's PureSecurity Electronic Monitoring Suite. The project will include the PureSecurity RF monitoring solution, providing continuous tracking of offenders in house arrest. The project is set to cover all EM offender programs within Croatia for a duration of five years. SuperCom expects to deploy the initial order and generate revenues shortly after the project launch.

08:46 EDT Conduent's subsidary announces renewed contract with STM - Conduent Transportation, a global business unit of Conduent Incorporated, announced that Societe de Transport de Montreal, STM, has renewed the company's contract for another three years to support seven transportation networks with maintenance and upgrades of their systems and ticketing equipment in the Montreal metropolitan area and Quebec City. STM serves as the delegated ticketing manager on behalf of the Autorite Regionale de Transport Metropolitain, owner of the ticketing system. The award comes as Conduent Transportation continues to build upon its international presence and expand around the world. As part of the renewal, Conduent will continue to manage and maintain the OPUS fare collection system across all public transportation networks. Conduent will also provide the necessary hardware and software upgrades to modernize the service for users, enabling future new functionalities such as contactless bank card payments and QR code ticket validation.

08:43 EDT Allogene announces preclinical publication results on allogeneic CAR T cells - Allogene Therapeutics announced the publication of preclinical study results demonstrating the superior long-term in vitro myeloma-killing activity of allogeneic anti-BCMA CAR T cells from healthy donors compared with anti-BCMA CAR T cells from patients with multiple myeloma. The findings were published in Cancer Research Communications, a journal of the American Association for Cancer Research. In this study, anti-BCMA CAR T cells were generated from young healthy donors and from patients with relapsed/refractory multiple myeloma and their profile, fitness and cytotoxic activity were compared. Results showed that: Healthy donors had higher T cell counts, a higher CD4/CD8 T cell ratio, and naive/stem cell memory phenotype compared with patients with relapsed multiple myeloma; Anti-BCMA allogeneic CAR T cells derived from healthy donors showed efficient killing of primary multiple myeloma cells across different patient sub-groups including those with high-risk disease; and In a subset of patient samples with low BCMA, the addition of a gamma secretase inhibitor increased the surface levels of BCMA and led to improved cytotoxic activity. Manufacturing T cells from a healthy donor allows for less product variability and eliminates both the risk of manufacturing failures and the requirement for bridging therapy by enabling treatment within days. In studies on the approved autologous CAR T therapies, up to 75% of patients required bridging therapy, up to 18% of patients received therapies that were not within the required manufacturing specifications, and up to 14% of patients did not receive cells in time for treatment. As part of Allogene's anti-BCMA strategy, the Company has two AlloCAR T trials underway investigating product candidates for the treatment of multiple myeloma. Allogene intends to provide a BCMA program clinical update by the end of 2022.

08:40 EDT NFI Group's ADL continues Hong Kong expansion, first electric bus order - NFI Group subsidiary Alexander Dennis Limited, ADL, announced that it is to build an initial 10 electric double deck buses for Hong Kong operator The Kowloon Motor Bus Company Limited, KMB. The zero-emission Enviro500EV will be ADL's first electric double deck buses in the Asia-Pacific region. Ten battery-electric Enviro500EV three-axle, fully air-conditioned double deck buses will be delivered to KMB in 2023 and will come with new and innovative features that will continue to raise the bar for efficiency, safety and comfort. "We acquired ADL in 2019 with a vision that it would drive our international growth strategy. Today's announcement, combined with other contract wins in Germany, Ireland and New Zealand, highlights that vision becoming reality," said Paul Soubry, President & CEO, NFI. "ADL has long been the world leader in double-deck buses and will continue to lead this space through the transition to zero-emission."

08:37 EDT TC Biopharm receives approvals to begin Ommnimmune therapy in AML - TC Biopharm has received MHRA and Research Ethics Committee approvals to initiate gamma-delta T cell therapy clinical trials of OmnImmune for the treatment of Acute Myeloid Leukemia, or AML. OmnImmune, an allogeneic unmodified cell therapy consisting of activated and expanded gamma delta T cells has already received orphan drug designation for the treatment of patients suffering from the blood and bone marrow cancer. Phase 2/3 trials will begin enrollment in the first half of 2022 in the UK with expansion into the US following shortly thereafter.

08:36 EDT Brink's BLUbeem now accessible in Clover app market - The Brink's Company announced the availability of its BLUbeem digital cash payment solution via Clover from Fiserv. "We're thrilled to be launching BLUbeem for Clover, one of the world's fastest-growing POS payment systems," said Rohan Pal, Brink's chief digital officer. "The combination of our digital cash payment technology and the Clover platform will enable merchants to significantly reduce time spent handling receipts, reduce losses, eliminate the risks associated with manual delivery of cash to the bank, and free up employees to focus on customer service and other important in-store tasks. On top of all these benefits, merchants receive bank credit and access to their funds within 24 hours." The BLUbeem app is available in the Clover App Market and is expected to be added to additional POS platforms in the first half of 2022.

08:35 EDT Heat Biologics appoints Burel to Biothreat Advisory Board, senior advisor - Heat Biologics announces the appointment of Greg Burel, former Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response Director of the Strategic National Stockpile, to the Company's Biothreat Advisory Board and as a senior advisor to the Company.

08:33 EDT Trecora Resources to 'carefully review and evaluate' Ortelius' board candidates - Trecora Resources issued the following statement regarding Ortelius Advisors' letter to Trecora stockholders yesterday: "Trecora's Board of Directors and management team are focused on delivering value for our shareholders. While we are confident that the Company is positioned for strong, profitable growth, we also remain open to exploring all value-enhancing opportunities. To that end, we have spoken with the principal of Ortelius on dozens of occasions over the past eighteen months and have considered his input seriously and objectively. In those conversations, Ortelius has made a wide assortment of claims and proposals. At various times, Ortelius has wanted us to: Enter into exclusive negotiations with Ortelius to sell it the Company (even though Ortelius did not indicate a buyout price or demonstrate that it had adequate financing); Support Ortelius in issuing a mini-tender offer to buy additional shares in the Company; Allow Ortelius to buy more than 15% of Trecora stock and waive the protections afforded to our other shareholders under Delaware corporate law; Have the Company conduct a Dutch-tender to buy our own stock while Ortelius also buys stock through a tender or in the open market; Add three new directors to the Board; Replace six directors on the Board; and Add three directors and remove two directors from the Board. Ortelius has also suggested several permutations of those ideas at various times. Despite professing an interest in buying all of Trecora (or a substantial minority interest in Trecora) at different times over the last eighteen months, Ortelius has never submitted an indication of value and has, oddly, refused to even sign a standard non-disclosure agreement so that the Company could provide Ortelius with the information it would seemingly need to make such a proposal. Ortelius now publicly claims to have a 'plan to improve operating and financial performance.' However, if this plan does exist, Ortelius has yet to share it with Trecora's Board or management team despite having had ample opportunity to do so. Nevertheless, Trecora's Board and management team have continued to engage constructively with Ortelius in good faith. In the Fall, for example, the Board interviewed three Ortelius director candidates and offered to appoint one of them to the Board, without even requesting a typical standstill. Ortelius curiously rejected this offer. Last month, Ortelius surprised us again by indicating its intention to nominate six directors to our seven-person Board. Ortelius appears now to be seeking to do at the ballot box what it has been, so far, unable and unwilling to do with a checkbook: acquire control of the Company without competition from other parties. Earlier this month, in an effort to avoid a costly and disruptive proxy contest, two of the Company's independent directors further engaged with the principal of Ortelius in order to find an amicable resolution. During this conversation, Ortelius suggested another new proposal, asking to seat three of its director candidates and for the Board to waive certain protective provisions of Delaware law, which would enable Ortelius to buy the Company later without customary protections for other shareholders. Despite this new request that again appears to favor only Ortelius' interests, the Trecora Board has begun the process of interviewing two of the latest director candidates that Ortelius has recommended to the Board, in an attempt to find a resolution that is in the best interest of all shareholders. In short, Ortelius' assertion in its letter that the Board has 'refused to genuinely engage' is simply false. Trecora's Board and management team have had dozens of interactions with Ortelius and considered almost as many new and seemingly impulsive ideas from Ortelius. Most of these suggestions do not appear to be about creating value for all our shareholders but rather aimed at providing Ortelius a special, substantial economic interest in Trecora, or control of Trecora, without Ortelius providing a premium to other shareholders. The Trecora Board will carefully review and evaluate the Board candidates proposed by Ortelius and will present its recommendations regarding the director election in the Company's definitive proxy statement to be filed with the U.S. Securities and Exchange Commission. The Company has not yet announced the date of its 2022 Annual Meeting of Stockholders."

08:30 EDT LanzaTech enters partnership with SHV Energy - SHV Energy and LanzaTech announced a new strategic partnership to employ LanzaTech's Carbon Capture and Transformation technology to bring renewable propane and other sustainable fuels to the market via existing and novel pathways. The collaboration will be dedicated to further expanding LanzaTech's existing CCT technology and synthetic biology platform which transform waste carbon into sustainable fuels and other materials such as fabrics, packaging, and other products. "This partnership shows the diversity of applications for recycled carbon. SHV Energy is a leader in finding new ways to de-fossilize energy applications and we are proud to see our proven technology bring recycled carbon into yet another sector of the economy that currently depends on virgin fossil carbon," said Jennifer Holmgren, CEO of LanzaTech. "Together we are showing the world that an alternative to our heavy reliance on virgin fossil fuels used in the manufacturing of so many consumer products, from textiles, packaging and aviation fuel to renewable propane, currently exists. This alternative, circular carbon economy, based on the readily available carbon already above ground, is large enough to make a meaningful long-term impact on our society's climate goals today. Now more than ever, we must embrace waste-based solutions that enable global energy security." LanzaTech announced March 8, 2022 it plan s to go public through a business combination transaction with AMCI Acquisition Corp.

08:25 EDT Rani Therapeutics announces initiation of Phase 1 study of RT-102 - Rani Therapeutics announced the initiation of a Phase 1 study of RT-102, an oral formulation of the human parathyroid hormone analog PTH for the treatment of osteoporosis, delivered via RaniPill capsule. Osteoporosis is a bone loss disease that affects approximately 10M Americans annually. "At Rani, our goal is to make oral biologics a reality. Today represents another step towards this goal with the progression of RT-102 into the clinic, an important milestone for Rani as we begin to evaluate PTH(1-34) delivered by the RaniPill capsule in human subjects," said Talat Imran, Chief Executive Officer of Rani Therapeutics. "Osteoporosis is a chronic and undertreated disease that often requires frequent and painful injections. We believe that RT-102 has the potential to advance treatment of osteoporosis and reach more patients by offering a convenient, oral option." The first subject has been administered RT-102 in the single-center, open label, Phase 1 study, which is being conducted in Australia. The study will evaluate the pharmacokinetics, safety, and tolerability of RT-102 administered in healthy adult women volunteers. RT-102 will be ingested orally, administering a single dose of parathyroid hormone.

08:22 EDT H2O Innovation expands specialty chemicals manufacturing plant in UK - H2O Innovation announces that its specialty chemical business line is doubling the footprint at their Cheshire, UK facility to keep up with demand. The grand opening ceremony for this new reverse osmosis, RO, cleaner production plant took place on Tuesday, March 15, 2022. The whole project is a $1.7 M investment to extend the Corporation's specialty chemicals production facilities required in part due to significant growth in demand for Genesys-PWT powdered membrane cleaners. The UK facility doubled in size to 30,000 ft squared with capacity to produce 1,000 tons/year of powder cleaners. The expansion created two more local chemical operator jobs and a role for an additional research and quality control chemist. "This builds strategically on the momentum of combining the strengths of Genesys and PWT to execute on the promise of delivering the best products from the best location through our distribution network to customers around the world. We are expecting to see an acceleration in powdered cleaner sales due to their lower water footprint which reduces freight costs and associated CO2 emissions compared to equivalent liquid products. These powdered products are in line with our ESG initiatives, and we are seeing increased demand from many customers for products that reduce environmental impact," added Frederic Dugre, President and Chief Executive Officer of H2O Innovation.

08:20 EDT Katapult Adyen hires new VP of Strategic Partnerships, VP of Strategy - Katapult (KPLT) announced it has hired Jay Diamonon as Katapult's Vice President, VP, of Strategic Partnerships and Eric Harmon as Vice President of Strategy and Corporate Development. Diamonon will take the lead in securing and managing Katapult's current and future retail partners, while Harmon will take the lead in defining Katapult's strategic priorities and initiatives to accelerate the company's growth. Prior to joining Katapult, Diamonon led the US sales team for Adyen (ADYEY). Harmon most recently held a position as executive director of alternative data product at UBS (UBS).

08:18 EDT EVgo selected for awards for two CEC CARTS grants to support Uber deal - EVgo (EVGO) announced that the company was selected for proposed awards for two California Energy Commission, CEC, Charging Access for Reliable On-Demand Transportation Services, CARTS, grants to directly support its partnership with Uber (UBER). Using the proposed award funds of over $3.6M, EVgo will develop twin public fast charging hub sites featuring 72 charging stalls -- including 38 designated for public use -- within Los Angeles and the Bay Area. As part of this program, all four of the new charging sites will feature fast charging up to 350 kW, ultimately aiding EVgo and Uber in their shared mission to electrify the rideshare industry and provide enhanced access to public EV fast charging infrastructure in rideshare-dense regions within California and beyond.

08:18 EDT BioSig Technologies announces closing of public offering of common stock - BioSig Technologies announced the completion of its previously announced underwritten public offering of 2,611,739 shares of its common stock, $0.001 par value per share, at a price to the public of $1.15 per share. The proceeds to BioSig from this offering were $3M. The Company also issued a cash warrant at $1.40. Fully exercised the Company will receive another $3M of cash proceeds. BioSig intends to use the net proceeds from the offering for the continuation of full commercialization activities related to the PURE EP System.

08:16 EDT Aytu BioScience announces newly issued patent from Cotempla XR-ODT - Aytu BioPharma announced that its newly issued U.S. patent No. 11,166,947 for Cotempla XR-ODT extended-release orally disintegrating tablet is now listed in the FDA publication, "Approved Drug Products with Therapeutic Equivalence Evaluations," commonly known as the "Orange Book." The Cotempla XR-ODT patent covers methods of use for the effective pediatric dosing of methylphenidate for the treatment of attention deficit hyperactivity disorder, or ADHD. Cotempla XR-ODT is an orally disintegrating tablet containing methylphenidate and is indicated for the treatment of ADHD in patients 6 to 17 years old. FDA approved the new drug application for Cotempla XR-ODT in June 2017. The United States Patent and Trademark Office, or USPTO-issued U.S. patent No. 11,166,947 entitled "Effective Dosing of a Child for the Treatment of ADHD with Methylphenidate" is now listed in the FDA's Orange Book and carries a patent term to at least 2038. The listing of this patent extends the Orange Book patent exclusivity for Cotempla XR-ODT by over five years.

08:13 EDT Cerence, PATEO selected by Hongqi Auto to provide in-vehicle assistant tech - Cerence announced that Hongqi Auto, the luxury automotive marque of China's FAW Group, has selected Cerence and PATEO CONNECT+ to provide connected and intelligent in-vehicle assistant technology as the automaker expands to international markets with its new E-HS9. The in-car assistant in the new Hongqi E-HS9 provides drivers with enhanced safety, comfort, and productivity while on the road. "Hongqi Auto is a prestigious brand that symbolizes the best in comfort and innovation, and its drivers expect the in-car assistant to be on par with the rest of the driving experience," said Stefan Ortmanns, CEO, Cerence. "We are proud to continue our fruitful partnership with PATEO to bring innovative, intelligent automotive technologies to this leading automaker as they bring their high-end lineup to new global markets, driving continued loyalty to the brand."

08:11 EDT Skillz announces multiyear partnership with UFC - Skillz announced a multi-year partnership with the UFC mixed martial arts organization. The licensing deal, which will enable Skillz' developers to create UFC-branded competitive mobile games that are co-marketed by UFC and Skillz, was revealed at the Game Developers Conference in San Francisco. Skillz is currently exhibiting March 23-25. "Skillz' partnership with UFC is part of our winning strategy that aligns Skillz' disruptive competitive mobile games platform with the business of sport. We're delivering an enticing opportunity for developers to create the most innovative, branded mobile games for UFC's millions of loyal fans worldwide," said Andrew Paradise, CEO of Skillz. "The popularity of the UFC brand, which represents one of the fastest- rising sports globally, combined with Skillz' mobile gaming expertise, is a huge win for developers seeking to monetize and grow their games through the power of competition. We look forward to nurturing this incredible collaboration to life in the coming months and years." The deal allows selected game creators from Skillz developer community to utilize certain UFC and UFC athlete intellectual property for mobile game creation and marketing. The new UFC-branded mobile games are slated to launch in 2023.

08:08 EDT Alta Equipment Group awarded Arizona sales, service territory for Nikola - Alta Equipment Group (ALTG) announced that it has been awarded the Arizona sales and service territory for Nikola Corporation (NKLA). This agreement further expands Alta's dealer territory with Nikola beyond the New York, New Jersey, eastern Pennsylvania and New England markets, as announced in August of 2021, and will replace Empire Transport in Arizona.

08:08 EDT ZIM Integrated updates on withholding tax procedures on April cash dividend - ZIM Integrated secured an extension of its previously obtained tax ruling from the Israeli Tax Authority with respect to the tax withholding procedures relating to the payment of dividend to its shareholders. The Ruling will apply to the dividend distribution expected to take place on April 4 and to any future dividend distributions to be made by the company on or before December 31, if declared by the company. As a result of the Ruling, certain Shareholders may be eligible to a reduced Israeli withholding tax rate with respect to their share of this Dividend distribution, in comparison to the generally applicable withholding tax rate, under certain terms and conditions as set forth below. Shareholders are advised to consult their own tax and financial advisors concerning the tax consequences of each particular situation, as well as any tax consequences that may arise under the laws of any state, local, foreign or other taxing jurisdiction.

08:06 EDT Wabtec announces multi-year modernization order from Norfolk Southern - Wabtec (WAB) announced an additional multi-year order from Norfolk Southern (NSC) to modernize 330 locomotives as part of its continued partnership. This deal is part of Norfolk Southern's ongoing efforts to further improve fuel efficiency and reduce emissions from its fleet. With each modernized locomotive, Norfolk Southern's carbon emissions are reduced by more than 500 tons per year. The deal marks the third major modernization order from the railroad since 2015, making it the largest modernized fleet in North America, with more than 950 locomotives upon completion in 2025. "Modernizing locomotives in our fleet will improve operational performance and reliability," said Tom Schnautz, Vice President Advanced Train Control for Norfolk Southern. "Importantly, it will also help us achieve our science-based target of a 42% reduction in emissions intensity by 2034. Wabtec's proven modernization program allows us to maximize the value of our locomotives, minimize the use of new materials, and reduce the environmental impact of our operations." Wabtec will modernize D9-44CW locomotives that are more than 20 years old and transform them into AC44C6Ms, which will add another 20 years of incremental life to each locomotive. The modernized locomotives will feature the FDL Advantage engine upgrade and a suite of digital solutions including Trip Optimizer, SmartHPT, and Distributed Power. The modernizations will yield significant dividends per locomotive, including fuel efficiency improved by as much as 25%; a more than 40% increase in reliability; haulage ability increased by up to 55%; and a reduction of maintenance, repair, and overhaul expenses by 20%.

08:03 EDT General Mills CEO: Operating environment 'remains as volatile as ever' - Chairman and CEO Jeff Harmening said input cost inflation is at historic levels with increasing variability, and disruptions continue to impact the company's supply chain. The company saw a faster than expected rebound in service in the final weeks of the quarter, Harmening said. Comments taken from Q3 earnings conference call prepared remarks.

08:01 EDT General Mills sees Q4 input cost inflation up double digits - Sees FY22 input cost inflation up 8%-9%. Sees organic price/mix stepping up from Q3 to Q4 and expects the operating environment to remain challenging in Q4. Comments taken from Q3 earnings conference call presentation slides.

07:56 EDT Agree Realty CEO buys $112K in common stock - In a regulatory filing, Agree Realty disclosed that its CEO Joey Agree bought 1.7K shares of common stock March 22 in a total transaction size of $112K.

07:47 EDT Hyzon Motors expects to deliver 300-400 vehicles in 2022 - Hyzon Motors expects to deliver 300-400 vehicles with deliveries heavily weighted towards the back half of the year as the industry navigates supply chain challenges and global uncertainties. Expects to commence assembling vehicles using our flagship, made in the USA, high power-density fuel cells during the second half of 2022. In North America, expects to have 10-15 Hyzon fuel cell demonstration trucks deployed to multiple trial customers by year end. In Europe, Australia, and China, expect to ramp up deliveries and streamline assembly processes to meet increasing demand. Anticipates a Hyzon / Raven gas-to-hydrogen hub and waste-to-hydrogen hub online by year end.

07:42 EDT Vectivbio presents preclinical data on apraglutide - VectivBio announced new preclinical data supporting the potential of apraglutide as a novel treatment of steroid-refractory GI aGVHD following allogeneic hemopoietic stem cell transplant, HSCT. The data were presented across four posters at the 48th Annual Meeting of the European Society for Blood and Marrow Transplantation, EBMT, taking place virtually March 19-23, 2022. Details of the e-poster presentations are as follows: Title: "Apraglutide Decreases Severity of Intestinal Damage from Gastrointestinal Acute Graft Versus Host Disease Following Allogeneic Transplantation Without Impacting Engraftment." Treatment with apraglutide prior to and following allogeneic transplantation in immunodeficient mice was observed to have a protective effect against the GI damage from conditioning chemotherapy. Notably, apraglutide did not appear to affect engraftment rate, and was observed to reduce GI damage and improve mortality rates in allogeneic-transplant-induced GvHD. Title: "Apraglutide Treatment Reduces Chemotherapy-Induced Gastrointestinal Damage in Mice and Preserves Cellular Integrity During Chemotherapy." Data showed that apraglutide protected GI epithelium structure from chemotherapy-induced injury, prevented severe body weight loss, and improved survival rates in mice undergoing chemotherapy. Additionally, apraglutide maintained plasma citrulline levels, a marker of intestinal mass, comparable to that in mice that did not undergo chemotherapy. The effects of apraglutide were optimal when it was administered as pre-treatment before chemotherapy. Title: "Treatment with Apraglutide Preserves the Global Homeostatic Environment of Intestinal Microbiota During Chemotherapy in Mice." In mouse models of aGVHD, the co-administration of apraglutide with conditioning chemotherapy avoided damage to the gut common from chemotherapy alone. Results showed the preservation of intestinal microbiome homeostasis, and improved outcomes including reduced body weight loss and increased survival rates. Title: "Apraglutide Does Not Impact Anti-tumor and Immunosuppressive Efficacy of Conditioning Chemotherapy in Mice." The administration of apraglutide as a pre- and concomitant treatment in mouse models of aGVHD did not impair the anti-tumor and immunosuppressive effects of chemotherapy. The pharmacologic effects of apraglutide were observed to be specific to the intestine.

07:39 EDT Worthington announces plans to set GHG emission reduction targets - Worthington Industries announced plans to set greenhouse gas, GHG, emissions reduction targets that are aligned with a 1.5 degree Celsius science-based target, setting a pathway to net-zero emissions by 2050. The Company will apply to the Science Based Targets initiative, SBTi, to attain formal verification later this year. Worthington also announced that the Company will strategically focus on products and services that support reductions in GHG emissions including its automotive lightweighting technologies, electrical steel laminations for electric vehicles, transformers and wind turbines, gas containment systems for the growing hydrogen ecosystem and connected products that support reduced fuel consumption. "Worthington's pledge to set emissions reduction targets aligned with a 1.5 degree Celsius science-based target clearly demonstrates our commitment to sustainability," said Worthington Industries President & CEO Andy Rose. "With Scope 3 emissions as our greatest environmental impact, we understand that it will take all of us working together to achieve our goals and enable a sustainable future for all." Rose added, "Worthington today has many products and solutions that enable emissions reductions, and we intend to increase our focus on these products to capitalize on the growth opportunity in those businesses."

07:38 EDT Nestle says focus in Russia to be on providing essential food, not on profit - Nestle issued the following update on Russia and Ukraine: "As the war rages in Ukraine, our activities in Russia will focus on providing essential food, such as infant food and medical/hospital nutrition - not on making a profit. This approach is in line with our purpose and values. It upholds the principle of ensuring the basic right to food. Going forward, we are suspending renowned Nestle brands such as KitKat and Nesquik, among others. We have already halted non-essential imports and exports into and out of Russia, stopped all advertising, and suspended all capital investment in the country. Of course, we are fully complying with all international sanctions on Russia. While we do not expect to make a profit in the country or pay any related taxes for the foreseeable future in Russia, any profit will be donated to humanitarian relief organizations. This is in addition to the hundreds of tons of food supplies and significant financial assistance that we have already contributed to support the people in Ukraine and refugees in neighboring countries. And these efforts will continue. We stand with the people of Ukraine and our 5,800 employees there." Reference Link

07:35 EDT Alliance Data to move forward as Bread Financial - Alliance Data announced it will now be known as Bread Financial, a tech-forward financial services company. The company's prior market-facing brands are now unified under the singular Bread Financial brand. The company's common stock will begin trading under a new ticker symbol (BFH) on the New York Stock Exchange on April 4. Bread Financial's two bank subsidiaries, Comenity Bank and Comenity Capital Bank, will retain their current names.

07:32 EDT Parsons to support NSA three-day cyber competition - Parsons will provide support to the National Security Agency's, NSA, three-day cyber competition - NSA Cyber Exercise, NCX - designed to enhance the full-spectrum cyber operational capabilities of U.S. Service Academies, senior military colleges, and current employees in NSA development programs. Parsons will plan, develop, implement, score, and facilitate five unclassified modules - cryptography, malware, software development, cyber policy, and cyber combat.

07:30 EDT Joint Corp. acquires regional developer territory of Northern New Jersey - The Joint Corp. acquired the regional developer territory of Northern New Jersey, representing four franchised clinics and the opportunity for additional corporate clinics, for $250,000 on March 17, 2022. "Focused on increasing our corporate clinic presence in the Northeast, The Joint acquired the regional developer territory in Northern New Jersey," said Peter D. Holt, President and Chief Executive Officer of The Joint Corp. "This purchase expands our platform to accelerate growth as we execute our long-standing strategy to open greenfield clinics within clusters. We continue to broaden brand recognition and drive toward our goal of 1,000 clinics opened by the end of 2023 and even more in the long term."

07:29 EDT Merck Research Laboratories CMO Roy Baynes to retire, Eliav Barr to succeed - Merck announced that Roy Baynes, head of global clinical development and CMO, Merck Research Laboratories, will be retiring from Merck in July. Baynes will be succeeded by Eliav Barr, effective April 1. Baynes will continue to report to Dean Li, president, Merck Research Laboratories, until his retirement.

07:22 EDT Osisko provides new results on Windfall gold project - Osisko Mining provides new analytical results from the ongoing drill program at its 100% owned Windfall gold project located in the Abitibi greenstone belt, Urban Township, Eeyou Istchee James Bay, Quebec. Expansion drilling in the Lynx 4 area has defined a new sub-vertical zone located 80 metres south-west of wireframe LX4-3449 and 150 metres under wireframe LX4-3451. The new mineralization is currently defined by 18 intercepts over an area measuring 200 metres x 300 metres. High-grade mineralization typical of the Lynx area defines the new zone with disseminated pyrite associated with strong pervasive silica alteration hosted in a sericitized rhyolite. This new zone is located outside the January 2022 mineral resource estimate. Osisko Chief Executive Officer John Burzynski commented: "The expansion program at Windfall continues to pay dividends as illustrated by today's announcement of a new zone outside our current resources. These results confirm how prolific the Lynx area is with respect to resource growth. We will continue to selectively target open areas where previous holes highlight strong potential for additional ounces."

07:20 EDT Berkshire Grey introduces robotic system for autonomous ecommerce autobagging - Berkshire Grey introduced its new Robotic Pick and Pack with Identification system, which now includes advanced auto-identification and item manipulation technology, for touchless eCommerce autobagging. Using Berkshire Grey's advanced AI-enabled robotic technology, this system combines automated picking with intelligent placement for packing eCommerce items directly into autobagging equipment. "Berkshire Grey's Robotic Pick and Pack with Identification system for autobagging is the newest addition to our innovative portfolio of eCommerce solutions," said Kishore Boyalakuntla, VP of Product at Berkshire Grey. "This system helps retailers increase their fulfillment throughput capacity while using sustainable autobagging approaches. With BG RPPi for eCommerce Autobagging, we can now help retailers enable a touchless pick-to-ship fulfillment operation that is fully autonomous, thereby reducing labor dependency and increasing overall productivity."

07:18 EDT CareDx announces XenoSure, XenoMap - CareD announced the availability of XenoSure donor-derived cell-free DNA and XenoMap gene-expression profiling for investigational use in xenotransplantation research and post-xenotransplant clinical monitoring. "The rate of innovation in xenotransplantation is accelerating, and CareDx is proud to be the diagnostic leader by introducing XenoSure and XenoMap as the first molecular surveillance testing services for research use in these medical breakthroughs," said Reg Seeto, CEO and President of CareDx. "XenoSure and XenoMap are now available for use in the clinical research setting to help monitor post-transplant organ health and generate insights to better understand how we can improve long-term outcomes."

07:16 EDT Flora Growth to expand presence in Europe with Greenyard, JustCBD pact - Flora Growth hat its brand JustCBD has partnered with German company Greenyard to open brick-and-mortar stores throughout Germany and the Czech Republic. In addition to the opening of brick-and-mortar stores, JustCBD products will be distributed by Greenyard throughout Germany, the Czech Republic, Poland, Austria, Switzerland, Ukraine, Georgia and Estonia. A total of four stores in Germany and the Czech Republic are under construction and are anticipated to open by the end of Q2, with up to 50 additional stores opening in 2023. The stores will carry JustCBD's complete product line, including gummies, tinctures, vape cartridges, creams, pet wellness, and more.

07:14 EDT Mogo Enthusiast forms Mogo Ventures to manage existing investments - Mogo (MOGO) announced the formation of Mogo Ventures to manage its existing investments in strategic partners and companies that support Mogo's ecosystem, including: a 39% stake in Coinsquare; investments in crypto and Web3 platforms including Gemini, NFT Trader and Tetra Trust; investments in gaming companies including Enthusiast Gaming (EGLX) and Eleven Gaming and investments in Bitcoin and Ether. Mogo Ventures will also manage the company's portfolio of legacy investments, including its investments in Hootsuite, Blue Ant Media and Alida, with a focus on monetizing these investments.

07:10 EDT HUB Security to become publicly traded through Mount Rainier Acquisition deal

07:07 EDT PVH Corp. adds Michael Calbert to board - PVH Corp. (PVH) announced that Michael Calbert, Chairman of the Board of Dollar General (DG), will join its Board of Directors, effective May 2. The company also announced that Henry Nasella, its non-executive Chair, will not stand for re-election at its June 16 annual meeting of stockholders. Both changes are part of the Board's previously disclosed refreshment process. Nasella has served on the Board for 19 years, including as presiding director since 2007 and Chair since 2021 when it first became an independent, non-executive role. Calbert is expected to succeed Nasella as Chair if Calbert is re-elected at the annual meeting. Calbert has served as Chairman of Dollar General since 2016 and formerly was a member of the private equity firm KKR & Co., where he led the Retail industry team from January 2000 until his retirement in 2014.

06:56 EDT GameStop Chairman Ryan Cohen buys 100,000 shares - In a regulatory filing, GameStop said Chairman Ryan Cohen bought 100,000 shares of the video game retailer on Tuesday. Cohen's RC Ventures paid between $96.81 an $108.82 for the GameStop shares, according to the filing.

06:46 EDT Pfizer reports 'positive' results from Phase 3 trial of etrasimod - Pfizer announced positive topline results from a Phase 3 study of etrasimod, an investigational, oral, once-a-day, selective sphingosine 1-phosphate receptor modulator in development for the treatment of moderately to severely active ulcerative colitis. In the study, etrasimod patients achieved statistically significant improvements in the primary endpoint of clinical remission at week 12 as compared with placebo. Statistically significant improvements were achieved in all key secondary endpoints in the trial as well. The safety profile was consistent with previous Phase 2 studies. "These positive results demonstrate that etrasimod, if approved, could be a potential breakthrough option for patients with ulcerative colitis who aren't able to experience improvement on current therapies," said Michael Corbo, Chief Development Officer, Inflammation & Immunology, Pfizer Global Product Development. "This outcome represents a continuation of our effort to develop new therapeutic approaches to treat immuno-inflammatory diseases and address the need for oral therapies for UC patients with inadequate response, loss of response, or intolerance to conventional or advanced therapies."

06:33 EDT Cresco Labs to acquire Columbia Care for $2B - Cresco Labs (CRLBF) and Columbia Care (CCHW) announced they have entered into a definitive arrangement agreement pursuant to which Cresco Labs will acquire all of the issued and outstanding shares of Columbia Care. Subject to customary closing conditions and necessary regulatory approvals, the Transaction is expected to close in the fourth quarter of 2022. Under the terms of the Arrangement Agreement, shareholders of Columbia Care will receive 0.5579 of a subordinate voting share of Cresco Labs for each Columbia Care common share held, subject to adjustment representing total consideration enterprise value of approximately $2B based on the closing price of Cresco Labs Shares on the Canadian Securities Exchange as of March 22. The Transaction provides Columbia Care Shareholders with premiums per Columbia Care Share of approximately 16% based on the closing prices of the Columbia Care Shares and the Cresco Labs Shares, and (ii) 19%, based on the 20-day volume weighted average prices of the Columbia Care Shares and the Cresco Labs Shares, each on the CSE as of March 22, 2022. After giving effect to the Transaction, Columbia Care Shareholders will hold approximately 35% of the pro forma Cresco Labs. The Arrangement Agreement provides for certain customary provisions, including covenants in respect of non-solicitation of alternative transactions, a right to match superior proposals, a $65M termination fee payable to Cresco Labs under certain circumstances.

06:05 EDT Theta Lake attracts $50M in series B funding - Theta Lake announced a $50M series B funding round led by Battery Ventures. The round also includes investments from existing investors such as Lightspeed Venture Partners, Neotribe Ventures and Cisco Investments (CSCO), as well as new investments from RingCentral Ventures (RNG), Salesforce Ventures (CRM), and Zoom Video Communications (ZM). The new investment brings the company's total funding raised to date to over $70M.

05:29 EDT Western Union announces Artajasa Pembayaran Elektronis as partner in Indonesia - Western Union has announced PT Artajasa Pembayaran Elektronis as its newest bank account and wallet payout partner in Indonesia. Artajasa is in the market of electronic transactions in Indonesia. The collaboration will enable customers to receive international money transfers in minutes into their bank accounts across all major banks in Indonesia. Payout into wallets will launch later this year.

05:15 EDT Guidewire opens new EMEA headquarters in Blanchardstown - Guidewire announced that it has opened its new EMEA headquarters 10 years after the company opened its first office in Dublin. Based in Blanchardstown, the new office building occupies 85,000 square feet. Guidewire is offering employees fully remote and hyperflexible working practices.

05:07 EDT Galiano Gold CFO Fausto Di Trapani to step down, Matt Freeman to succeed - Galiano Gold announced that Fausto Di Trapani, Galiano's CFO has informed the company that he will be stepping down as CFO to pursue another opportunity. Fausto will continue to serve as CFO until his departure in early May and will work during the coming weeks to ensure an orderly transition of his responsibilities. Following Fausto's departure the company intends to appoint Matt Freeman, current SVP Finance as its new CFO, in line with the company's succession plan.